Results 201 to 210 of about 94,755 (223)

Human Angiopoietin-like Protein 3/ANGPTL3 Antibodies: Adding to the Armamentarium in the Management of Dyslipidemia

Journal of Cardiovascular Pharmacology, 2021
Abstract: Cardiovascular (CV) disease remains the leading cause of death in the United States. In addition to lifestyle modifications, current guidelines primarily focus on lowering low-density lipoprotein cholesterol (LDL-C) to reduce atherosclerotic CV disease risk.
openaire   +2 more sources

Angiopoietin-Like Protein 3 Directly Regulates HDL Metabolism and Function

Diabetes, 2018
Background: Angiopoietin-like protein 3 (ANGPTL3) is produced by hepatocytes. Once secreted, it inhibits endothelial lipase activity and regulates angiogenesis. We previously reported the positive association between serum ANGPTL3 and HDL function in nondiabetic participants. Hereby, we investigated whether ANGPTL3 directly modulates HDL function.
LONGYAN YANG, YAN WANG, YING FU, JIANAN LANG, DONG ZHAO, YINGMEI FENG   +5 more
openaire   +1 more source

Angiopoietin-like protein 3 and 4 expression 4 and their serum levels in hepatocellular carcinoma

Cytokine, 2017
Hepatocellular carcinoma (HCC) is the 6th most common cancer and the 3rd leading cause of cancer causing death allover the world. The aim of this research to explore the clinical relevance of blood angiopoietin-like protein-3 (ANGPTL3) and ANGPTL4 expression and their proteins levels as non invasive biomarkers in cirrhotic and HCC patients and their ...
Amal S, El-Shal, Haidy E, Zidan, Nearmeen M, Rashad, Fady M, Wadea   +3 more
openaire   +2 more sources

Angiopoietin-like protein 3 inhibitors and contemporary unmet needs in lipid management

Current Opinion in Lipidology, 2021
Qidi, Ying, Dick C, Chan, Gerald F, Watts   +2 more
openaire   +2 more sources

Angiopoietin-like protein 4 (ANGPTL4) is an inhibitor of endothelial lipase (EL) while the ANGPTL4/8 complex has reduced EL-inhibitory activity

Heliyon, 2021
Yan Q Chen, Robert W Siegel, Mariam Ehsani   +2 more
exaly  

Angiopoietin-like protein 3 and adiponectin levels in patients with metabolic syndrome.

Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2011
To investigate the changes of serum angiopoietin-like protein 3 (Angptl3) and adiponectin levels in patients with metabolic syndrome (MS) in order to understand their association with the MS.Serum Angptl3 and adiponectin levels were measured by sandwich ELISA in a group of 111 patients with MS and 152 normal controls.Serum adiponectin was lower in the ...
Wanbei, Guo, Zhihong, Che, Aimin, Xu, Zhiguang, Zhou   +3 more
openaire   +1 more source

Angiopoietin‐2 and angiopoietin‐like 4 protein provide prognostic information in patients with suspected acute coronary syndrome

Journal of Internal Medicine, 2021
Reidun Aarsetøy, Thor Ueland, Pal Aukrust   +2 more
exaly  

Angiopoietin-like 2 Protein and Hidradenitis Suppurativa: A New Biomarker for Disease Severity

Biomedicines, 2023
JOSÉ L Hernández, J Gonzalo Ocejo-Vinyals, Mónica Renuncio-García   +2 more
exaly  

Angiopoietin-Like Protein 3 Inhibition

Journal of the American College of Cardiology
Erik S.G. Stroes, Bram M. Weijs, Maxim E. Annink   +2 more
openaire   +1 more source

Changes in serum levels of angiopoietin-like protein-8 and glycosylphosphatidylinositol-anchored high-density lipoprotein binding protein 1 after ezetimibe therapy in patients with dyslipidemia

Clinica Chimica Acta, 2020
Akihito Ideishi, Yasunori Suematsu, Kohei Tashiro   +2 more
exaly